Clinical trial
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or…
NCT00096265 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00096265 |
|---|---|
| Title | Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer |
| Official title | A Phase III Trial Comparing Whole Brain Radiation and Stereotactic Radiosurgery Alone Versus With Temozolomide or Erlotinib in Patients With Non-Small Cell Lung Cancer and 1-3 Brain Metastases |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Collaborators | Radiation Therapy Oncology Group |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Malignant Neoplasm in the Brain, Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer AJCC v7 |
| Intervention type | Drug, Radiation |
| Interventions | 3-Dimensional Conformal Radiation Therapy, Erlotinib Hydrochloride, Stereotactic Radiosurgery, Temozolomide |
| Enrollment | 126 |
| Start date | Oct 6, 2004 |
| Primary completion | Jun 14, 2011 |
| Completion | Apr 1, 2012 |
| First posted | Nov 9, 2004 |
| Last update posted | Mar 9, 2018 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: